Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha

British Journal of Pharmacology
B M Kromer, J R Tippins

Abstract

1. This study was undertaken to compare the effects of 8-epi prostaglandin F2 alpha (8-epi PGF2 alpha) to those of prostaglandin F2 alpha (PGF2 alpha) and U46619, a thromboxane mimetic, on ovine, bovine and porcine coronary arteries. 2. 8-epi PGF2 alpha constricted porcine and bovine coronary arteries in a concentration-dependent manner with EC50 values of 689.0 +/- 229.3 and 1361.0 +/- 272.3 nM, respectively, but had no effect on ovine coronary arteries. 3. U46619 was a potent vasoconstrictor of porcine, ovine and bovine coronary arteries with EC50 values of 33.0 +/- 23.5, 373.3 +/- 69.7 and 254.1 +/- 134.3 nM, respectively. Emax values were significantly greater than those obtained with 8-epi PGF2 alpha. 4. PGF2 alpha constricted procine and bovine coronary arteries in a concentration-dependent manner with EC50 values of 1631.0 +/- 207.6 and 3644.0 +/- 344.8 nM, respectively, but had no effect on ovine coronary arteries. 5. Concentration-dependent constriction to U46619 in porcine coronary arteries was competitively inhibited by SQ29548 (10(-8) M to 10(-7) M) and BM13505 (10(-8) M to 10(-6) M) with no decrease in maximal responses. 6. Concentration-dependent constriction to 8-epi PGF2 alpha in porcine coronary arteries was in...Continue Reading

References

Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J D MorrowL J Roberts
Feb 4, 1989·BMJ : British Medical Journal·M D StringerV V Kakkar
Jan 1, 1988·Free Radical Biology & Medicine·B Hennig, C K Chow
Nov 15, 1994·Annals of the New York Academy of Sciences·L J Roberts, J D Morrow
Feb 1, 1994·European Heart Journal·J L Dubois-RandéY Grosgogeat
Feb 1, 1994·International Journal of Cardiology·M ChandraV C Pandey
Jan 3, 1994·Biochimica Et Biophysica Acta·J D MorrowL J Roberts
Jun 1, 1993·The American Journal of Physiology·M FukunagaK F Badr
Jan 12, 1996·Biochemical Pharmacology·J D Morrow, L J Roberts
Oct 1, 1995·Journal of Lipid Mediators and Cell Signalling·P V HalushkaK L Davis-Bruno

❮ Previous
Next ❯

Citations

May 16, 2001·Arthritis and Rheumatism·J L CracowskiG Bessard
Mar 9, 2005·Biochemical and Biophysical Research Communications·François ValentinMark C Field
Mar 24, 2004·Chemistry and Physics of Lipids·Kevin Moore
Mar 24, 2004·Chemistry and Physics of Lipids·Jean-Luc Cracowski
Mar 24, 2004·Chemistry and Physics of Lipids·L J Janssen
Oct 25, 2003·Life Sciences·Roswitha M WolframHelmut Sinzinger
Sep 9, 1999·European Journal of Pharmacology·W SametzR Wintersteiger
Oct 16, 2002·Trends in Pharmacological Sciences·Jean-Luc CracowskiGermain Bessard
Jan 12, 2001·Journal of the American College of Cardiology·L IulianoF Violi
Feb 2, 2002·Journal of the American College of Cardiology·Jean Luc CracowskiGermain Bessard
Jan 1, 1997·Free Radical Biology & Medicine·R J WaughR C Murphy
Jul 11, 2001·Trends in Endocrinology and Metabolism : TEM·D PraticòG A FitzGerald
Nov 25, 2003·Prostaglandins & Other Lipid Mediators·Indra Neil Guha, Kevin Moore
Apr 16, 1999·British Journal of Pharmacology·B M Kromer, J R Tippins
Mar 11, 2000·British Journal of Pharmacology·L OliveiraD J Crankshaw
Apr 20, 2001·British Journal of Pharmacology·J H CranshawJ A Mitchell
Nov 13, 1998·Current Opinion in Lipidology·J L Witztum, J A Berliner
Sep 9, 2005·Critical Care Medicine·Ahamed H IdrisAndrea Gabrielli
Apr 28, 2005·Clinical and Experimental Pharmacology & Physiology·Claire ArnaudChristophe Ribuot
Sep 12, 2009·Circulation Research·Volker Rudolph, Bruce A Freeman
Apr 29, 2008·American Journal of Respiratory Cell and Molecular Biology·Luke J Janssen
Feb 27, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Daiji TakeuchiMaya Fujiwara
Jun 12, 2008·Redox Report : Communications in Free Radical Research·Slavica RadovanovicTatjana Simic
Jun 18, 2014·Cardiovascular Research·S Christopher HiettAlexander G Obukhov
Jul 25, 2009·British Journal of Pharmacology·R L JonesD F Woodward
Apr 2, 1999·Prostaglandins, Leukotrienes, and Essential Fatty Acids·E MichoudN Wiernsperger
Oct 20, 2001·Redox Report : Communications in Free Radical Research·S K LimB Halliwell
Apr 19, 2015·European Heart Journal·Keyvan Karimi GalougahiGemma A Figtree
Aug 10, 2000·Pulmonary Pharmacology & Therapeutics·L J Janssen
Aug 26, 2014·Oxidative Medicine and Cellular Longevity·Kamila SyslováPetr Kačer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.